These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4087685)

  • 1. Bladder secretion of inhibitors of calcium oxalate crystal growth.
    Martin X; Opgennorth TJ; Werness PG; Rundquist RT; Romero JC; Smith LH
    Kidney Int; 1985 Oct; 28(4):636-9. PubMed ID: 4087685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of saline bladder washings on calcium oxalate crystal growth and aggregation.
    Edyvane KA; Ryall RL; Marshall VR
    J Urol; 1985 Jul; 134(1):158-61. PubMed ID: 4009815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of urinary macromolecules on calcium oxalate monohydrate crystal growth.
    Lanzalaco AC; Singh RP; Smesko SA; Nancollas GH; Sufrin G; Binette M; Binette JP
    J Urol; 1988 Jan; 139(1):190-5. PubMed ID: 3336094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcium oxalate crystallization in urine.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1987; 15(2):83-6. PubMed ID: 3590434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective urinary crystallization inhibition and urinary stone formation.
    Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
    Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of traditional risk factors for stone disease on calcium oxalate crystal adherence in the rat bladder.
    Smith CL; St Peter JV
    Urol Res; 2007 Oct; 35(5):243-6. PubMed ID: 17668198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation.
    Thongboonkerd V; Chutipongtanate S; Semangoen T; Malasit P
    J Urol; 2008 Apr; 179(4):1615-9. PubMed ID: 18295252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y; Ahmed M; Hall SL; Deganello S; Coe FL
    J Clin Invest; 1987 Jun; 79(6):1782-7. PubMed ID: 3584470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that nephrocalcin and urine inhibit nucleation of calcium oxalate monohydrate crystals.
    Asplin J; DeGanello S; Nakagawa YN; Coe FL
    Am J Physiol; 1991 Nov; 261(5 Pt 2):F824-30. PubMed ID: 1951713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis.
    Grover PK; Thurgood LA; Ryall RL
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1396-403. PubMed ID: 17267387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.